BiomX (PHGE)
(Delayed Data from AMEX)
$0.19 USD
+0.01 (5.56%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $0.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for BiomX Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 25 | 27 | 35 | 30 | 22 |
Income After Depreciation & Amortization | -25 | -27 | -35 | -30 | -22 |
Non-Operating Income | 2 | 1 | 0 | 0 | 2 |
Interest Expense | 2 | 2 | 1 | 0 | 0 |
Pretax Income | -26 | -28 | -36 | -30 | -21 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -26 | -28 | -36 | -30 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -26 | -28 | -36 | -30 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -24 | -24 | -33 | -28 | -22 |
Depreciation & Amortization (Cash Flow) | 1 | 3 | 3 | 2 | 0 |
Income After Depreciation & Amortization | -25 | -27 | -35 | -30 | -22 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 51.33 | 29.85 | 26.01 | 23.06 | 5.62 |
Diluted EPS Before Non-Recurring Items | -0.51 | -0.95 | -1.39 | -1.30 | -3.66 |
Diluted Net EPS (GAAP) | -0.51 | -0.95 | -1.39 | -1.30 | -3.66 |
Fiscal Year end for BiomX Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.79 | 5.28 | 7.79 | 6.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.79 | -5.28 | -7.79 | -6.08 |
Non-Operating Income | NA | -9.69 | 0.30 | 0.47 | 0.42 |
Interest Expense | NA | 0.85 | 0.52 | 0.57 | 0.75 |
Pretax Income | NA | -17.32 | -5.49 | -7.90 | -6.40 |
Income Taxes | NA | 0.01 | 0.00 | 0.01 | 0.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -17.33 | -5.49 | -7.91 | -6.41 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -17.33 | -5.49 | -7.91 | -6.41 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 62.29 | 68.64 | 60.59 | 51.55 |
Diluted EPS Before Non-Recurring Items | NA | -0.15 | -0.08 | -0.13 | -0.12 |
Diluted Net EPS (GAAP) | NA | -0.28 | -0.06 | -0.13 | -0.12 |